Dexamethasone at discharge for COVID-19 does not reduce readmission, mortality - Healio

Continued use of dexamethasone after hospital discharge was not associated with a reduction in readmission or mortality among patients with COVID-19, researchers reported in JAMA Network Open. Cheng-Wei Huang, MD, a physician at Kaiser Permanente Los An…

Continued use of dexamethasone after hospital discharge was not associated with a reduction in readmission or mortality among patients with COVID-19, researchers reported in JAMA Network Open. Cheng… [+1958 chars]

full article...